For pharma

Reach the providers before the treatment decision.

Your team already has a target list. What it doesn’t have is timing. Hyperdrive adds intent signals from proprietary real-time claims and lab data, so brand and field teams know which providers are about to make a treatment decision.

What you get

Timing, added to the providers you already target

  • 01

    Provider-level intent signals

    Signals that a diagnostic or treatment decision is coming, tied to the providers and accounts your team cares about.

  • 02

    Enriched provider profiles

    Verified contact and practice information, affiliations and payers, so each signal reaches the right person.

  • 03

    Delivered where your team works

    In your CRM or as a working list for brand and field teams, on a cadence that fits your program.


Built responsibly

Provider-level signals, de-identified data

  • Signals are delivered at the provider level.
  • Patient-level data is de-identified under HIPAA Safe Harbor or by Expert Determination before it is used.
  • Every provider resolves to a real NPI and practice, with verified contact detail.

Questions

Common questions from pharma teams

Where do the signals come from?

From proprietary real-time claims and lab data, matched to the provider. We walk through the sources that apply to your indication on a call.

How is this different from the target list we already have?

Your list tells you who could prescribe. Intent signals tell you who is about to make a treatment decision, so your team can prioritize this week’s outreach.

Is patient-level data shared?

No. Patient-level data is de-identified under HIPAA Safe Harbor or by Expert Determination, and signals are delivered at the provider level.


Book a call

See the signals in your market

Tell us the brand and the indication. On a short call we’ll walk through what Hyperdrive would surface for your team.